← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 5, 2019Last known activity
Jun 16, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (12)
- NCT05861674Lead sponsorPhase 2Jun 16, 2023
- NCT05787418Lead sponsorPhase 3Mar 31, 2023
- NCT05713318Lead sponsorPhase 2Jan 18, 2023
- NCT05753878Lead sponsorPhase 1Nov 8, 2022
- NCT05734807Lead sponsorPhase 2Jul 20, 2022
- NCT06039163Lead sponsorPhase 1Apr 16, 2022
- NCT05275465Lead sponsorPhase 1Apr 11, 2022
- NCT05116865Study directorPhase 1Nov 30, 2021
- NCT05116865Lead sponsorPhase 1Nov 30, 2021
- NCT05839639Lead sponsorPhase 2Oct 9, 2021
- NCT05674448Lead sponsorPhase 2Aug 11, 2021
- NCT05542979Lead sponsorPhase 1Aug 5, 2019
Details
- Last known activity
- Jun 16, 2023